U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2005
130
Substance Class Protein
Created
by admin
on Mon Mar 31 18:42:43 GMT 2025
Edited
by admin
on Mon Mar 31 18:42:43 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
7D0YB67S97
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ORENCIA
Preferred Name English
ABATACEPT
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
ABATACEPT RECOMBINANT
Common Name English
ABATACEPT [USAN]
Common Name English
1-25-ONCOSTATIN M (HUMAN PRECURSOR) FUSION PROTEIN WITH CTLA-4 (ANTIGEN) (HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN HEAVY CHAIN FRAGMENT) (RECOMBINANT)
Common Name English
ABATACEPT [VANDF]
Common Name English
ABATACEPT [EMA EPAR]
Common Name English
ABATACEPT [PURPLE BOOK CDER]
Common Name English
ABATACEPT [MI]
Common Name English
abatacept [INN]
Common Name English
BMS-188667
Code English
Abatacept [WHO-DD]
Common Name English
RG-1046
Code English
ABATACEPT [JAN]
Common Name English
ABATACEPT [MART.]
Common Name English
ABATACEPT (GENETICAL RECOMBINATION)
JAN  
Common Name English
CTLA4-IGG4M
Code English
ABATACEPT (GENETICAL RECOMBINATION) [JAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C574
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
NDF-RT N0000169367
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
NDF-RT N0000182159
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
FDA ORPHAN DRUG 556216
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
FDA ORPHAN DRUG 395713
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
WHO-VATC QL04AA24
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
EMA ASSESSMENT REPORTS ORENCIA (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
WHO-ATC L04AA24
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
LIVERTOX NBK548442
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
NDF-RT N0000008571
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
EMA ASSESSMENT REPORTS ORENCIA (AUTHORIZED: ARTHRITIS, JUVENILE RHEUMATOID)
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
NDF-RT N0000011180
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
NDF-RT N0000175446
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
FDA ORPHAN DRUG 556316
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
FDA ORPHAN DRUG 614117
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL1201823
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
RXCUI
614391
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY RxNorm
EVMPD
SUB20635
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
JAPANESE REVIEW
ORENCIA
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY APPROVED JULY 2010
WIKIPEDIA
ABATACEPT
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
USAN
NN-82
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
CAS
332348-12-6
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
DAILYMED
7D0YB67S97
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
INN
8495
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
SMS_ID
100000089557
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
DRUG BANK
DB01281
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
MERCK INDEX
m1274
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY Merck Index
LACTMED
Abatacept
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
MESH
C468566
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
FDA UNII
7D0YB67S97
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
IUPHAR
6891
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
NCI_THESAURUS
C28898
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
DRUG CENTRAL
5089
Created by admin on Mon Mar 31 18:42:43 GMT 2025 , Edited by admin on Mon Mar 31 18:42:43 GMT 2025
PRIMARY
From To
2_303 2_361
2_197 2_257
2_74 2_92
2_47 2_118
1_303 1_361
1_197 1_257
1_146 2_146
1_74 1_92
1_47 1_118
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_102
N 1_134
N 1_233
N 2_102
N 2_134
N 2_233
Related Record Type Details
T-LYMPHOCYTE ACTIVATION ANTIGEN CD80
TARGET -> INHIBITOR
T-LYMPHOCYTE ACTIVATION ANTIGEN CD86
TARGET -> INHIBITOR
Related Record Type Details
ABATACEPT
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER AVERAGE(MALDI-TOF) CHEMICAL
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966